2024-11-18 00:41:52
Zuberitamab (Anruixi®), the first domestically developed anti-CD20 antibody as a Class I innovative drug from BioRay Pharmaceutical, has been approved for marketing in China
Health/ 2023-09-14
Zuberitamab (Anruixi®), the first domes...

SHANGHAI,Sept. 13,2023--Recently,BioRay Pharmaceutical Co.,Ltd. (hereinafter referred to as "Bioray") announced that its independe...

Singleron launches AccuraCode® TCR library construction kit, enhancing efficiency and cost-effectiveness of high-throughput T-cell receptor profiling
Health/ 2023-09-14
Singleron launches AccuraCode® TCR libr...

COLOGNE,Germany,Sept. 13,2023-- Singleron has announced the launch of its AccuraCode® TCR library construction kit for high-throughput T...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release